Advertisement
Screener

CRONOS GROUP INC. (CRON) Increase (Decrease) in Operating Capital

2.8 / 5 stars · 68/120 Roast Me

CRONOS GROUP INC. Increase (Decrease) in Operating Capital

CRONOS GROUP INC. (CRON) reported Increase (Decrease) in Operating Capital of $33.94 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-26.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOperatingCapital · last filed 2021-02-26

  • CRONOS GROUP INC. increase (decrease) in operating capital for the quarter ending 2020-12-31 was $4.82M, a 83.44% decline year-over-year.
  • CRONOS GROUP INC. increase (decrease) in operating capital for the quarter ending 2020-09-30 was -$1.45M, a 141.26% decline year-over-year.
  • CRONOS GROUP INC. increase (decrease) in operating capital for the quarter ending 2020-06-30 was $15.09M, a 57.75% decline year-over-year.
  • CRONOS GROUP INC. increase (decrease) in operating capital for the quarter ending 2020-03-31 was $15.48M.
  • CRONOS GROUP INC. increase (decrease) in operating capital for fiscal 2020 was $33.94M, a 37.38% decline from fiscal 2019.
  • CRONOS GROUP INC. increase (decrease) in operating capital for fiscal 2019 was $54.21M.
  • CRONOS GROUP INC. increase (decrease) in operating capital for fiscal 2018 was -$3.66M, a 582.48% decline from fiscal 2017.
  • CRONOS GROUP INC. increase (decrease) in operating capital for fiscal 2017 was $759.00K.
Period endIncrease (Decrease) in Operating Capital 3 monthIncrease (Decrease) in Operating Capital 6 monthIncrease (Decrease) in Operating Capital 9 monthIncrease (Decrease) in Operating Capital 12 month
2020-12-31$4.82M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26
$3.37M
derived: sum of 2 quarters · filed 2021-02-26
$18.46M
derived: sum of 3 quarters · filed 2021-02-26
$33.94M
10-K · filed 2021-02-26
2020-09-30-$1.45M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$13.64M
derived: sum of 2 quarters · filed 2020-11-05
$29.12M
10-Q · filed 2020-11-05
$58.23M
derived: sum of 4 quarters · filed 2021-02-26
2020-06-30$15.09M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
$30.57M
10-Q · filed 2020-08-06
$59.68M
derived: sum of 3 quarters · filed 2021-02-26
$63.19M
derived: sum of 4 quarters · filed 2021-02-26
2020-03-31$15.48M
10-Q · filed 2020-05-08
$44.59M
derived: sum of 2 quarters · filed 2021-02-26
$48.10M
derived: sum of 3 quarters · filed 2021-02-26
$83.81M
derived: sum of 4 quarters · filed 2021-02-26
2019-12-31$29.11M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26
$32.62M
derived: sum of 2 quarters · filed 2021-02-26
$68.33M
derived: sum of 3 quarters · filed 2021-02-26
$54.21M
10-K · filed 2021-02-26
2019-09-30$3.51M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$39.22M
derived: sum of 2 quarters · filed 2020-11-05
$25.10M
10-Q · filed 2020-11-05
2019-06-30$35.71M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
$21.59M
10-Q · filed 2020-08-06
2019-03-31-$14.12M
10-Q · filed 2020-05-08
2018-12-31-$3.66M
10-K · filed 2021-02-26
2017-12-31$759.00K
10-K/A · filed 2020-03-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87